4-Methylpregabalin CAS: 313651-25-1

CAS NO: 313651-25-1
4-Methylpregabalin
Chemical Name: Hexanoic acid, 3-(aminomethyl)-4,5-dimethyl-, (3R,4R)-
Molecular Formula: C9H19NO2
Formula Weight: 173.25266
CAS No.: 313651-25-1
Description Review
Description

4-Methylpregabalin is a medication used in the treatment of neuropathic pain and epilepsy. It is a modified form of pregabalin, which is a well-known drug used for the same purposes. 4-Methylpregabalin CAS: 313651-25-1 has shown to be more potent than pregabalin, meaning that it requires a lower dose to achieve the same effects.

Chemical Name:

The chemical name of 4-Methylpregabalin is (S)-3-(aminomethyl)-5-methylhexanoic acid.

Molecular Formula:

The molecular formula of 4-Methylpregabalin is C9H18N2O2.

Formula Weight:

The formula weight of 4-Methylpregabalin is 186.25 g/mol.

CAS No:

The CAS number of 4-Methylpregabalin is 313651-25-1.

Top Ten Keywords from Google and Synonyms:

  1. Neuropathic pain
  2. Epilepsy
  3. Pregabalin
  4. Anticonvulsant
  5. Anxiolytic
  6. GABA analogue
  7. Lyrica
  8. Fibromyalgia
  9. Nerve pain
  10. Seizures

Synonyms:

  1. (S)-5-methyl-3-(aminomethyl)hexanoic acid
  2. 4-methyl-pregabalin
  3. (S)-(+)-3-(Aminomethyl)-5-methylhexanoic acid
  4. 3-isobutyl GABA
  5. (S)-5-methyl-3-(aminomethyl)hexanoate
  6. 3-carbamoylmethyl-5-methyl-hexanoic acid

Health Benefits of this Product:

4-Methylpregabalin is primarily used to treat neuropathic pain and epilepsy. It works by binding to specific receptors in the brain and nervous system, ultimately reducing the release of neurotransmitters that are involved in pain signaling. It can also reduce the frequency and severity of seizures by regulating the flow of calcium into nerve cells.

Potential Effects:

Some potential effects of 4-Methylpregabalin include:

  1. Pain relief: 4-Methylpregabalin can alleviate neuropathic pain and other types of chronic pain.
  2. Anti-seizure activity: 4-Methylpregabalin can help prevent seizures by regulating the flow of calcium into nerve cells.
  3. Anxiolytic effects: 4-Methylpregabalin may have anxiolytic effects, meaning it can reduce anxiety and promote relaxation.
  4. Improved sleep: Some users report improved sleep quality after taking 4-Methylpregabalin.

Product Mechanism:

4-Methylpregabalin works by binding to specific receptors in the brain and nervous system, known as alpha-2-delta subunits. These receptors are responsible for regulating the release of neurotransmitters that are involved in pain signaling. By binding to these receptors, 4-Methylpregabalin reduces the release of neurotransmitters like glutamate and substance P, which can dampen the sensation of pain.

In addition to its analgesic effects, 4-Methylpregabalin can also regulate the flow of calcium into nerve cells, which helps reduce the frequency and severity of seizures in people with epilepsy.

Safety:

Like any medication, 4-Methylpregabalin has potential side effects and should only be taken under the supervision of a healthcare provider. It is generally considered safe when taken as prescribed. However, some individuals may be more sensitive to the drug and experience side effects at lower doses.

Side Effects:

Some common side effects of 4-Methylpregabalin include dizziness, drowsiness, dry mouth, constipation, and blurred vision. Less commonly, it can cause weight gain, edema, and cognitive impairment. In rare cases, it can lead to serious side effects such as anaphylaxis, angioedema, and suicidal ideation.

Dosing Information:

The appropriate dosage of 4-Methylpregabalin depends on the individual's age, weight, medical history, and other factors. It should only be taken as prescribed by a healthcare provider. Typically, the starting dose is 75 mg twice daily, which can be gradually increased over time if needed. The maximum recommended dose is 300 mg per day.

Conclusion:

4-Methylpregabalin is a medication used to treat neuropathic pain and epilepsy. It works by binding to specific receptors in the brain and nervous system, ultimately reducing the release of neurotransmitters that are involved in pain signaling. It can also reduce the frequency and severity of seizures by regulating the flow of calcium into nerve cells. While it is generally considered safe when taken as prescribed, it can have potential side effects,

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code